Trials / Sponsors / iRegene Therapeutics Co., Ltd.
iRegene Therapeutics Co., Ltd.
Industry · 5 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of Parkinson Disease | Phase 1 | 2026-01-12 |
| Recruiting | A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy Multiple System Atrophy - Parkinsonian Subtype (MSA-P) | Phase 1 | 2026-01-05 |
| Not Yet Recruiting | The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease Parkinson Disease (PD) | Phase 2 | 2025-06-30 |
| Recruiting | The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease Early-onset Parkinson's Disease | Phase 1 | 2024-08-23 |
| Recruiting | The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease Parkinson Disease | Phase 1 / Phase 2 | 2024-01-17 |